BaroSense Eyes $30M For Obesity Device Published: Mar 26, 2009 VentureWire Lifescience -- Obesity device company BaroSense Inc. is looking to raise up to $30 million in Series D financing to reach commercialization, the company told VentureWire. Related links Dow Jones This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news